ATX 0.00% 6.2¢ amplia therapeutics limited

2 Aug 22. First Patient Recruited to ACCENT Trial in Pancreatic...

  1. 2,125 Posts.
    lightbulb Created with Sketch. 667
    2 Aug 22. First Patient Recruited to ACCENT Trial in Pancreatic Cancer

    29 Nov 22. ACCENT Trial Recruitment Progress

    11 Jan 23. Dose Escalation Approved in ACCENT Clinical Trial of AMP945

    28 Feb 23. ACCENT Trial Recruitment Progress

    19 April 23. First Patient Recruited to Cohort 3 of ACCENT Trial in Pancreatic Cancer

    9 May 23 ACCENT Trial Recruitment Progress

    2 Aug 23. ACCENT Trial Recruitment Update

    30 Nov 23. AMPLIA REPORTS PROMISING CLINICAL DATA
    FROM PHASE 1B PORTION OF THE ACCENT TRIAL IN PANCREATIC CANCER

    Love the 30th Nov update …

    So yes, there has been plenty of updates along the way.

    Reading through some of these announcements theres not been any suggestion of any difficulty recruiting patients.

    Hopefully as we progress there will be more updates of what’s happening both here and Korea

    .

    .
 
watchlist Created with Sketch. Add ATX (ASX) to my watchlist
(20min delay)
Last
6.2¢
Change
0.000(0.00%)
Mkt cap ! $12.02M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 150000 6.1¢
 

Sellers (Offers)

Price($) Vol. No.
6.2¢ 180369 2
View Market Depth
Last trade - 16.12pm 03/05/2024 (20 minute delay) ?
ATX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.